Update on Current Care Guideline : Migraine
Mild migraine attack can be treated with acetaminophen or NSAIDs either alone or combined with metoclopramide. In severe and devastating attacks triptans should be taken immediately, and not afterwards, when first line NSAIDs have proven ineffektive. No significant differences between triptans can be shown in clinical practice, when recommended doses are used. Opioid analgesics should not be used in the treatment of migraine. The recommended drugs for migraine attacks in children are acetaminophen or ibuprophen. Also intranasal sumatriptan can be used. The first line drugs for prophylactic treatment of migraine are non-ISA betablockers or candesartan and amitriptyline.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:131 |
|---|---|
| Enthalten in: |
Duodecim; laaketieteellinen aikakauskirja - 131(2015), 19 vom: 14., Seite 1823-5 |
| Sprache: |
Finnisch |
|---|
| Weiterer Titel: |
Migreeni |
|---|
| Anmerkungen: |
Date Completed 14.01.2016 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM255302584 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM255302584 | ||
| 003 | DE-627 | ||
| 005 | 20231224174219.0 | ||
| 007 | tu | ||
| 008 | 231224s2015 xx ||||| 00| ||fin c | ||
| 028 | 5 | 2 | |a pubmed24n0851.xml |
| 035 | |a (DE-627)NLM255302584 | ||
| 035 | |a (NLM)26638667 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fin | ||
| 245 | 1 | 0 | |a Update on Current Care Guideline |b Migraine |
| 246 | 3 | 3 | |a Migreeni |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 14.01.2016 | ||
| 500 | |a Date Revised 03.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Mild migraine attack can be treated with acetaminophen or NSAIDs either alone or combined with metoclopramide. In severe and devastating attacks triptans should be taken immediately, and not afterwards, when first line NSAIDs have proven ineffektive. No significant differences between triptans can be shown in clinical practice, when recommended doses are used. Opioid analgesics should not be used in the treatment of migraine. The recommended drugs for migraine attacks in children are acetaminophen or ibuprophen. Also intranasal sumatriptan can be used. The first line drugs for prophylactic treatment of migraine are non-ISA betablockers or candesartan and amitriptyline | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Adrenergic beta-Antagonists |2 NLM | |
| 650 | 7 | |a Analgesics, Non-Narcotic |2 NLM | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 650 | 7 | |a Angiotensin II Type 1 Receptor Blockers |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 650 | 7 | |a Benzimidazoles |2 NLM | |
| 650 | 7 | |a Biphenyl Compounds |2 NLM | |
| 650 | 7 | |a Dopamine D2 Receptor Antagonists |2 NLM | |
| 650 | 7 | |a Tetrazoles |2 NLM | |
| 650 | 7 | |a Tryptamines |2 NLM | |
| 650 | 7 | |a Vasoconstrictor Agents |2 NLM | |
| 650 | 7 | |a Amitriptyline |2 NLM | |
| 650 | 7 | |a 1806D8D52K |2 NLM | |
| 650 | 7 | |a Acetaminophen |2 NLM | |
| 650 | 7 | |a 362O9ITL9D |2 NLM | |
| 650 | 7 | |a Sumatriptan |2 NLM | |
| 650 | 7 | |a 8R78F6L9VO |2 NLM | |
| 650 | 7 | |a Metoclopramide |2 NLM | |
| 650 | 7 | |a L4YEB44I46 |2 NLM | |
| 650 | 7 | |a candesartan |2 NLM | |
| 650 | 7 | |a S8Q36MD2XX |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Duodecim; laaketieteellinen aikakauskirja |d 1945 |g 131(2015), 19 vom: 14., Seite 1823-5 |w (DE-627)NLM000016136 |x 0012-7183 |7 nnns |
| 773 | 1 | 8 | |g volume:131 |g year:2015 |g number:19 |g day:14 |g pages:1823-5 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 131 |j 2015 |e 19 |b 14 |h 1823-5 | ||